Acerca de
Nuestra Labor
Datos y herramientas
Eventos
Noticias
Emna-Gouider-is-nominated-as-VP-NMO - EN2

La doctora Emna Gouider nominada como vicepresidente para ONM de la FMH

La Federación Mundial de Hemofilia (FMH) tiene el enorme gusto de anunciar que la doctora Emna Gouider fue nominada como vicepresidente para organizaciones nacionales miembros (ONM) de la FMH a partir del 25 de abril de 2024, por un periodo de dos años.

También disponible en: English Français

La doctora Emna Gouider, hematóloga residente en Túnez, ha trabajado en el campo de los trastornos de la coagulación hereditarios por más de dos décadas. Durante nueve años ha sido voluntaria de la Asociación Tunecina de Hemofilia, la ONM de la FMH, ocupando diversos cargos, entre ellos el de miembro de su consejo directivo. Actualmente es asesora médica y científica de la ONM. Es también jefe del Centro de Tratamiento de Hemofilia (CTH) en Túnez.

Al colaborar con la FMH como líder de la ONM tunecina, Gouider logró crear un exitoso programa nacional de tratamiento de la hemofilia; trabajar estrechamente con los gobiernos a fin de establecer un proceso de licitación para la compra de concentrados de factor de coagulación; establecer un centro de tratamiento de hemofilia especializado, con un equipo multidisciplinario capacitado; e implementar un programa de profilaxis con dosis bajas para niños. También ha trabajado para acabar con algunos tabús sociales, con el propósito de incrementar el enfoque en mujeres y niñas con trastornos de la coagulación en su país.

La invaluable experiencia de Emna Gouider como vicepresidente para ONM será de gran valor para la FMH. Acompáñenos a darle la bienvenida al consejo directivo de la FMH.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.